期刊
CANCER LETTERS
卷 329, 期 2, 页码 125-136出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2012.11.001
关键词
MicroRNA; Biomarkers; Diagnosis; Prognosis; Circulation; Cancer
类别
资金
- American Cancer Society-Research Scholar Grant in Basic, Preclinical, Clinical and Epidemiology Research [115154AF109040]
- National Cancer Institute [(NCI)-R01CA161837-01]
- VA-Merit grant [I01 CX000512-01, NCI-5U24CA11509]
MicroRNAs (miRNAs) regulate the expression of approximately 30% of protein-coding genes. Functions of miRNAs are essential to maintain a steady state of cellular machinery. Dysregulations of miRNAs play pivotal roles in the initiation and progression of malignancies. Abnormal miRNA expressions have been found in a variety of human solid tumors. Furthermore, extracellular miRNAs could circulate in body fluids, and hence show great promise for refining diagnosis and prognosis of cancer. Here we review the progress of analysis of microRNAs as a potential approach for diagnosis and prognosis of solid cancer. We will also discuss obstacles in developing miRNAs as circulating biomarkers. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据